Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Retail ETF
XRT
|
+$391M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$370M |
| 3 |
CPN
Calpine Corporation
CPN
|
+$359M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$269M |
| 5 |
Gilead Sciences
GILD
|
+$242M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.08B |
| 2 |
Home Depot
HD
|
+$425M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$329M |
| 4 |
Wells Fargo
WFC
|
+$237M |
| 5 |
Vodafone
VOD
|
+$217M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 5.8% |
| 2 | Technology | 4.73% |
| 3 | Financials | 4.42% |
| 4 | Communication Services | 3.81% |
| 5 | Real Estate | 3.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SFXE
3951
DELISTED
SFX ENTERTAINMENT, INC COM
SFXE
| $464K | ﹤0.01% |
66,198
+65,243
| +6,832% | +$583K |
|
3952
CALL
Brown-Forman Class B
BF.B
$13.1B
| $463K | ﹤0.01% |
+16,250
| New | +$426K |
|
|
3953
PUT
Brown-Forman Class B
BF.B
$13.1B
| $463K | ﹤0.01% |
+16,250
| New | +$426K |
|
3954
PUT
FTI Consulting
FCN
$4.18B
| $462K | ﹤0.01% |
14,000
+10,000
| +250% | +$351K |
|
3955
Pan American Silver
PAAS
$21.6B
| $462K | ﹤0.01% |
38,499
-18,786
| -33% | -$252K |
|
|
SWC
3956
CALL
DELISTED
Stillwater Mining Co
SWC
| $462K | ﹤0.01% |
33,000
-11,700
| -26% | -$159K |
|
|
BRLI
3957
CALL
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $462K | ﹤0.01% |
17,100
+2,800
| +20% | +$73.3K |
|
3958
Vanda Pharmaceuticals
VNDA
$302M
| $461K | ﹤0.01% |
28,769
-299,569
| -91% | -$4.26M |
|
3959
PUT
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.93M
| $461K | ﹤0.01% |
9,400
+7,200
| +327% | +$344K |
|
|
RATE
3960
DELISTED
Bankrate Inc
RATE
| $461K | ﹤0.01% |
28,835
+22,436
| +351% | +$393K |
|
|
VNET
3961
VNET Group
VNET
$2.09B
| $460K | ﹤0.01% |
16,433
-9,300
| -36% | -$232K |
|
3962
PUT
Invesco
IVZ
$13.9B
| $458K | ﹤0.01% |
12,400
+11,000
| +786% | +$381K |
|
3963
SunCoke Energy
SXC
$797M
| $458K | ﹤0.01% |
20,831
+308
| +2% | +$6.78K |
|
|
RSTI
3964
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $458K | ﹤0.01% |
19,920
+1,870
| +10% | +$44.8K |
|
|
JASO
3965
PUT
DELISTED
JA Solar Holdings, Co., Ltd
JASO
| $457K | ﹤0.01% |
45,700
+31,500
| +222% | +$317K |
|
3966
Criteo S.A. Ordinary Shares
CRTO
$923M
| $455K | ﹤0.01% |
11,359
+9,819
| +638% | +$406K |
|
|
AFSI
3967
PUT
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $455K | ﹤0.01% |
+24,600
| New | +$431K |
|
3968
CALL
Neurocrine Biosciences
NBIX
$16.6B
| $454K | ﹤0.01% |
28,400
-161,800
| -85% | -$2.77M |
|
3969
Sanofi
SNY
$104B
| $453K | ﹤0.01% |
8,758
-10,748
| -55% | -$544K |
|
|
WW
3970
DELISTED
WW International
WW
| $453K | ﹤0.01% |
22,614
+4,033
| +22% | +$102K |
|
|
EPB
3971
PUT
DELISTED
EL PASO PIPELINE PARTNERS, L.P. COM UNITS REPSTG LTD PART
EPB
| $453K | ﹤0.01% |
15,100
+7,300
| +94% | +$232K |
|
3972
ASE Group
ASX
$82.2B
| $452K | ﹤0.01% |
90,520
-459,356
| -84% | -$2.25M |
|
3973
Minerals Technologies
MTX
$2.34B
| $452K | ﹤0.01% |
7,048
-2,704
| -28% | -$153K |
|
3974
CALL
Banco Bradesco
BBD
$36.7B
| $451K | ﹤0.01% |
88,521
+31,199
| +54% | +$141K |
|
|
NSLR
3975
Neostellar Capital Corp
NSLR
$254M
| $451K | ﹤0.01% |
69,454
+51,949
| +297% | +$419K |
|
Similar funds
Barclays's Q1 2014 Portfolio in Review
As of Q1 2014, Barclays held 8,036 positions worth $88.3B, down 9.5% from $97.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Barclays withdrew a net $11.2B in Q1 2014, closing 382 positions and reducing 4,029 holdings. Its most notable exit was LIFE TECHNOLOGIES CORP COM STK (DE), an estimated $136M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 5.8% of assets, up from 5.2% a quarter earlier, followed by Technology and Financials.
Against the trend, Barclays opened a new position in LIN MEDIA LLC CLASS A COM worth $23.4M.
- Barclays's largest Q1 2014 buy was LIN MEDIA LLC CLASS A COM: 898,200 shares worth $23.4M.
- Barclays added most to State Street SPDR S&P Retail ETF in Q1 2014, an estimated $391M increase.
- Barclays's biggest Q1 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.08B.
- Barclays fully exited LIFE TECHNOLOGIES CORP COM STK (DE) in Q1 2014, selling an estimated $136M.
- Barclays's ten largest holdings make up 22% of its $88.3B portfolio in Q1 2014.
- Barclays opened 459 new positions and closed 382 in Q1 2014.
- Barclays's portfolio value fell 9.5% quarter-over-quarter to $88.3B.
Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.